Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | SI | P14410 | 2/20 | 0.60 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | KDM6B | O15054 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15847228 | 1.00 | MGAM (0.60) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL9280063 | 1.00 | MGAM (0.60) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL28224529 | 1.00 | MGAM (0.60) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL2532133 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL22472179 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL25283117 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL5481698 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL17994176 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL4990677 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL17105598 | 0.97 | MGAM (0.57) | MGAMGAASIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11975023-B2 | Methods for inhibiting anaerobic microorganisms | LPOXY THERAPEUTICS, INC (US) | 2024-05-07 | — | — | US | claimed |
| US-11944641-B2 | Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy | LPOXY THERAPEUTICS, INC. (US) | 2024-04-02 | — | — | US | claimed |
| US-11883428-B2 | Enteric aerobization therapy | LPOXY THERAPEUTICS, INC. (US) | 2024-01-30 | — | — | US | claimed |
| CN-112852301-B | Photosensitive color-changing pencil paint and process for producing photosensitive color-changing pencil by using same | 中国第一铅笔有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-111718484-B | High-performance dynamic cross-linked polymer based on vinyl hydrazide bond and preparation method thereof | 四川大学 | 2021-10-12 | — | — | CN | claimed |
| CN-108441028-B | Photosensitive ink material and preparation method thereof | 深圳市格莱特印刷材料有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112844374-A | Mn-Ce-Ti oxide aerogel denitration catalyst and preparation method and application thereof | 上海应用技术大学 | 2021-05-28 | — | — | CN | claimed |
| CN-111718484-A | High-performance dynamic cross-linked polymer based on vinyl hydrazide bond and preparation method thereof | 四川大学 | 2020-09-29 | — | — | CN | claimed |
| CN-107163205-B | A kind of unsaturated polyester (UP) performed polymer of ketone group containing and its preparation method and application | 常州大学 | 2019-03-22 | — | — | CN | claimed |
| CN-108441028-A | A kind of photosensitive ink material and preparation method thereof | 深圳市格莱特印刷材料有限公司 | 2018-08-24 | — | — | CN | claimed |
| CN-101012291-A | Encapsulated michael addition catalyst | ROHM & HAAS (US) | 2007-08-08 | — | — | CN | claimed |
| CN-1898330-A | Multifunctional acrylate oligomers as pigment grinding vehicles for radiation-curable ink applications | ASHLAND LICENSING & INTELLECTU (US) | 2007-01-17 | — | — | CN | claimed |
| CN-1894291-A | Radiation curable inks for offset and screen printing applications made from multifunctional acrylate oligomers | ASHLAND LICENSING & INTELLECTU (US) | 2007-01-10 | — | — | CN | claimed |
| CN-1267209-C | Method for using Michael addition composite | ROHM & HAAS (US) | 2006-08-02 | — | — | CN | claimed |
| WO-2006002031-A1 | SUSTAINED RELEASE DOSAGE FORMS | ANDRX CORPORATION (US) | 2006-01-05 | — | — | WO | claimed |
| US-20050276849-A1 | Sustained release dosage forms | ANDRX CORPORATION | 2005-12-15 | — | — | US | claimed |
| CN-1708401-A | Liquid uncrosslinked michael addition oligomers prepared in the presence of a catalyst having both an epoxy moiety and a quaternary salt | ASHLAND INC (US) | 2005-12-14 | — | — | CN | claimed |
| EP-1097216-A1 | METABOLICALLY ENGINEERED MICROBIAL CELL WITH AN ALTERED METABOLITE PRODUCTION | Nielsen, Jens (DK) | 2001-05-09 | — | — | EP | claimed |
| WO-2000003020-A1 | METABOLICALLY ENGINEERED MICROBIAL CELL WITH AN ALTERED METABOLITE PRODUCTION | NIELSEN JENS (DK) | 2000-01-20 | — | — | WO | claimed |
| US-5811121-A | PH-sensitive coatings based on cellulose acetoacetate | EASTMAN CHEMICAL COMPANY (US) | 1998-09-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975023-B2 | Methods for inhibiting anaerobic microorganisms | SI, MB, ALPI | MGAM 62/4885GAA 436/4885SI 1/4885 |
| US-11883428-B2 | Enteric aerobization therapy | SI, MB, LPO | MGAM 18/4885GAA 434/4885SI 1/4885 |
| US-11944641-B2 | Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy | MB, NOD2, SI | MGAM 150/4885GAA 588/4885SI 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.